Paper
dd, 1H, J6a′,6b′ = 12.0 Hz, H-6a′), 4.46 (dd, 1H, J5′,6a′ = 4.9 Hz,
Organic & Biomolecular Chemistry
(
Methyl 4,6-di-O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-
H-6b′), 4.22–4.09 (m, 3H, J5′,6b′ = 2.6 Hz, H-5, 5′, 6a), 3.79 (dd, 2,3-di-O-benzyl-α-D-glucopyranoside (25) was obtained from
7
1
1
H, J6a,6b = 7.8 Hz, J5,6a = 3.4 Hz, H-6b), 2.94 (s, 3H, OCH
ppm.
Ethyl 2,3,4-tri-O-benzoyl-6-O-(2,3,4,6-tetra-O-benzoyl-β-D-glu- Analytical data for 25: R = 0.36 (ethyl acetate/hexane, 35/65,
3
)
donor 1 and acceptor 14
under the general glycosylation
method A in 41% yield (β only) as a white amorphous solid.
f
2
3
1
3 3
copyranosyl)-1-thio-β-D-glucopyranoside (21) was obtained v/v); [α] + 26.8 (c 1.0, CHCl ); H NMR (300 MHz, CDCl ): δ
D
6
5
from donor 1 and acceptor 10 under the general glycosyla- 8.12–7.77 (m, 16H, aromatic), 7.62–7.21 (m, 34H, aromatic),
tion method A in 16% yield (β only) as an off-white amorphous 5.75 (dd, 1H, J3′,4′ = 9.5 Hz, H-3′), 5.66 (dd, 1H, J3″,4″ = 9.7 Hz,
solid. The analytical data for 21 was in accordance with that H-3″), 5.59–5.53 (m, 2H, H-4′, 4″), 5.50–5.43 (m, 2H, J2′,3′ = 9.5,
6
7 1
previously reported.
H NMR (300 MHz, CDCl
3
): δ 8.02–7.23
J
2″,3″ = 9.7 Hz, H-2′, 2″), 4.90 (dd, 2H, CH
2
Ph), 4.63 (d, 1H, J1′,2′
= 7.6 Hz, H-1′), 4.59 (d, 1H, J = 10.0 Hz, CHPh), 4.49–4.38 (m,
.5 Hz, H-3′), 5.63 (dd, 1H, J4,5 = 9.7 Hz, H-4), 5.51 (dd, 1H, J2,3 4H, J1,2 = 3.4 Hz, H-1, 6a′, 6b′, CHPh), 4.32 (d, 1H, J1″,2″ = 7.5
9.7 Hz, H-2), 5.40 (dd, 1H, J2′,3′ = 9.7 Hz, H-2′), 5.31 (dd, 1H, Hz, H-1″), 4.07 (dd, 1H, J6a″,6b″ = 12.7 Hz, H-6a″), 3.99 (dd, 1H,
2
(m, 35H), 5.88 (dd, 1H, J3,4 = 9.6 Hz, H-3), 5.81 (dd, 1H, J3′,4′
=
9
=
J4′,5′ = 9.7 Hz, H-4′), 4.99 (d, 1H, J1,2 = 7.8 Hz, H-1), 4.65 (d, 1H, H-6b″), 3.91–3.83 (m, 2H, J3,4 = 10.7 Hz, H-3, 6a), 3.66–3.60 (m,
J1′,2′ = 10.0 Hz, H-1′), 4.58 (dd, 1H, J6a,6b = 12.1 Hz, H-6a), 4.40 3H, H-5, 5′, 6b′), 3.56 (dd, 1H, J4,5 = 3.7 Hz, H-4), 3.38 (dd, 1H,
(
dd, 1H, H-6b), 4.13–3.83 (m, 4H, J5,6a = 3.0, J5,6b = 5.0 Hz, H-5, 2,3 = 9.4 Hz, H-2), 3.30 (m, 1H, J5″,6a″ = 2.0, J5″,6b″ = 3.6 Hz,
J
1
3
H-5′, 6a′, 6b′), 2.52 (m, 2H, SCH CH ), 1.10 (t, 3H, SCH CH ) H-5″), 3.18 (s, 3H, OCH ) ppm; C NMR (75 MHz, CDCl ): δ
2
3
2
3
3
3
ppm.
p-Tolyl
glucopyranosyl)-1-thio-β-D-glucopyranoside (22) was obtained 129.7 (×4), 129.6 (×5), 129.3, 129.2, 129.1 (×2), 128.9, 128.8,
166.1 166.0, 165.5 (×2), 165.4, 165.3, 165.2, 164.8, 138.2, 137.9,
2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzoyl-β-D- 133.4, 133.3, 133.2 (×2), 133.0 (×3), 132.9, 130.0, 129.8 (×4),
6
6
from donor 1 and acceptor 11 under the general glycosyla- 128.5 (×2), 128.4 (×6), 128.3 (×6), 128.2 (×4), 128.1 (×3), 128.0
tion method A in 42% yield (β only) as a white amorphous (×3), 127.9, 127.4 (×3), 127.1, 101.6, 101.5, 97.9, 80.0, 79.6,
solid. The analytical data for 22 was in accordance with that 79.2, 74.5, 73.6, 73.2, 72.9, 72.6, 72.3, 72.2, 71.8, 69.7, 69.2,
6
8 1
+
previously reported.
m, 39H, aromatic), 5.84 (dd, 1H, J3′,4′ = 9.6 Hz, H-3′), 5.67 (dd, for C89
H, J4′,5′ = 9.6 Hz, H-4′), 5.58 (dd, 1H, J2′,3′ = 9.6 Hz, H-2′), 4.93 Methyl
3
H NMR (300 MHz, CDCl ): δ 7.93–7.09 68.9, 68.3, 63.5, 62.4, 55.4 ppm; HR-FAB MS [M + Na] calcd
(
1
H
78
O
24Na 1553.4781, found 1553.4755.
6-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-
(d, 1H, J1′,2′ = 7.8 Hz, H-1′), 4.86–4.80 (m, 2H, 2 × CHPh), 2,3,4-tri-O-benzyl-α-D-glucopyranoside (37) was obtained from
4
.74–4.39 (m, 7H, H-1, 6a′, 6b′, 4 × CHPh), 4.13 (d, 1H, J6a,6b
=
donor 26 and acceptor 2 under the general glycosylation
1
1.4 Hz, H-6a), 3.87–3.82 (m, 1H, H-5′), 3.85 (dd, 1H, H-6b), method A in 97% yield (β only) as a white amorphous solid.
3
.57 (dd, 1H, J3,4 = 8.3 Hz, H-3), 3.42–3.33 (m, 3H, J5,6a = 4.2 The analytical data for 37 was in accordance with that pre-
7
4 1
Hz, H-2, 4, 5), 2.34 (s, 3H, CH
3
) ppm.
3
viously reported. H NMR (300 MHz, CDCl ): δ 8.09–7.11 (m,
(
3β)-Cholest-5-en-3-yl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyra- 35H, aromatic), 5.97 (d, 1H, J4′,5′ = 2.7 Hz, H-4′), 5.85, (dd, 1H,
noside (23) was obtained from donor 1 and acceptor 12 under 2′,3′ = 10.4 Hz, H-2′), 5.60 (dd, 1H, J3′,4′ = 3.5 Hz, H-3′) 4.90 (d,
the general glycosylation method A in 77% yield (β only) as a 1H, J = 10.9 Hz, CHPh), 4.76 (d, 1H, J1′,2′ = 8.0 Hz, H-1′), 4.72
J
2
2
2
white solid. The analytical data for 23 was in accordance with (d, 1H, J = 12.0 Hz, CHPh), 4.69 (d, 1H, J = 10.9 Hz, CHPh),
6
9 1
2
that previously reported.
7
H NMR (300 MHz, CDCl
3
): δ 8.01, 4.67 (dd, 1H, J6a′,6b′ = 11.3 Hz, H-6a′), 4.58 (d, 1H, J = 12.0 Hz,
.96, 7.90 and 7.84 (4 d, 8H, aromatic), 7.57–7.26 (m, 12H, aro- CHPh), 4.56 (d, 1H, J = 11.2 Hz, CHPh), 4.51 (d, 1H, J1,2 = 3.5
matic), 5.90 (dd, 1H, J3,4 = 9.7 Hz, H-3), 5.63 (dd, 1H, H-4), 5.50 Hz, H-1), 4.40 (dd, 1H, H-6b′), 4.38 (d, 1H, J = 11.2 Hz, CHPh),
dd, 1H, J2,3 = 9.7 Hz, H-2), 5.22 (d, 1H), 4.94 (d, 1H, J1,2 = 7.9 4.24–4.19 (m, 1H, J5′,6a′ = 6.4, J5’,6b′ = 6.8 Hz, H-5′), 4.21 (dd,
Hz, H-1), 4.60 (dd, 1H, J6a,6b = 12.0 Hz, H-6a), 4.52 (dd, 1H, 1H, J6a,6b = 12.7 Hz, H-6a), 3.89 (dd, 1H, J3,4 = 9.2 Hz, H-3),
H-6b), 4.18–4.12 (m, 1H, J5,6a = 3.3, J5,6b = 5.9 Hz, H-5), 3.53 3.77–3.74 (m, 2H, J5,6a = 4.2 Hz, H-5, H-6b), 3.40 (dd, 1H, J2,3
2
2
(
=
3
(m, 1H), 2.17–2.16 (m, 2H), 2.02–1.69 (m, 2H), 1.60–1.57 (m, 9.6 Hz, H-2), 3.38 (dd, 1H, H-4), 3.20 (s, 3H, OCH ) ppm.
1
H), 0.91 (d, 3H, J = 6.5 Hz), 0.89 (s, 3H), 0.87 (d, 3H, J = 6.6
Methyl 6-O-(2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl)-
2,3,4-tri-O-benzyl-α-D-glucopyranoside (38) was obtained from
Hz), 0.86 (d, 3H, J = 6.6 Hz), 0.65 (s, 3H) ppm.
-Adamantyl
24) was obtained from donor 1 and acceptor 13 under the method A in 92% yield (α only) as a white amorphous solid.
general glycosylation method A in 96% yield (β only) as a The analytical data for 38 was in accordance with that pre-
1
2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside donor 27 and acceptor 2 under the general glycosylation
(
6
3 1
white solid. The analytical data for 24 was in accordance viously reported. H NMR (300 MHz, CDCl
with that previously reported.
8
5
3
): δ 8.09–7.25 (m,
): δ 35H, aromatic), 6.07 (dd, 1H, J4′,5′ = 10.0 Hz, H-4′), 5.86 (dd,
.03–7.90 (m, 8H, aromatic), 7.85–7.26 (m, 12H, aromatic), 1H, J3′,4′ = 3.1 Hz, H-3′), 5.72 (dd, 1H, J2′,3′ = 1.7 Hz, H-2′), 5.15
.92 (dd, 1H, J3,4 = 9.6 Hz, H-3), 5.55 (dd, 1H, J4,5 = 10.0 Hz, (d, 1H, J1′,2′ = 1.5 Hz, H-1′), 5.00 (dd, 2H, CH Ph), 4.84–4.78 (m,
7
0 1
H NMR (300 MHz, CDCl
3
2
H-4), 5.49 (dd, 1H, J2,3 = 8.0 Hz, H-2), 5.13 (d, 1H, J1,2 = 7.9 2H, 2 × CHPh), 4.70–4.61 (m, 4H, J1,2 = 3.6 Hz, H-1, 6a′,
Hz, H-1), 4.59 (dd, 1H, J6a,6b = 11.9 Hz, H-6a), 4.48 (dd, 1H, CH Ph), 4.40–4.35 (m, 1H, J = 4.3 Hz, H-5′), 4.30 (dd, 1H,
2
5′,6a′
H-6b), 4.19 (ddd, 1H, J5,6a = 3.0 Hz, J5,6b = 7.1 Hz, H-5), 2.02 H-6b′), 4.03 (dd, 1H, J3,4 = 9.2 Hz, H-3), 3.96–3.91 (dd, 1H,
s, 3H), 1.82 (d, 3H, J = 11.3 Hz), 1.63 (d, 3H, J = 11.4 Hz), H-6a), 3.88–3.78 (m, 2H, J5,6a = 4.9 Hz, H-5, 6b), 3.58–3.49 (m,
(
1
.50 (dd, 6H) ppm.
2H, J4,5 = 9.3 Hz, H-2, 4), 3.45 (s, 3H, OCH ) ppm.
3
3228 | Org. Biomol. Chem., 2021, 19, 3220–3233
This journal is © The Royal Society of Chemistry 2021